The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nacon SAS
LSE:0A9N
|
FR |
|
Pharmanutra SpA
MIL:PHN
|
IT |
|
F
|
Fobi AI Inc
SWB:WMV
|
CA |
|
Grasim Industries Ltd
NSE:GRASIM
|
IN |
|
S
|
Sebang Co Ltd
KRX:004360
|
KR |
|
MARUWA Co Ltd
F:6X5
|
JP |
|
Twilio Inc
NYSE:TWLO
|
US |
|
Tracsis PLC
F:4T2
|
UK |
|
Bellsystem24 Holdings Inc
TSE:6183
|
JP |
|
Cicor Technologies Ltd
SIX:CICN
|
CH |
|
Carlo Gavazzi Holding AG
LSE:0QL5
|
CH |
|
D
|
Device ENG Co Ltd
KOSDAQ:187870
|
KR |
|
L
|
Land Securities Group PLC
F:LSU2
|
UK |
|
BW LPG Ltd
NYSE:BWLP
|
SG |
|
Sika AG
SIX:SIKA
|
CH |
|
Perion Network Ltd
NASDAQ:PERI
|
IL |
|
Neptune Insurance Holdings Inc
NYSE:NP
|
US |
|
R
|
Rhythm Pharmaceuticals Inc
F:1RV
|
US |
|
M
|
MSTNS Co Ltd
KOSDAQ:257370
|
KR |
|
Zalaris ASA
OSE:ZAL
|
NO |
Nacon SAS (0A9N)’s 12-month stock price forecast through November 2027 has a consensus target of €0.0497, implying 22% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
0A9N is 0.0497 EUR with a low forecast of 0.0492 EUR and a high forecast of 0.0511 EUR.
Over the last 7 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 4%.
Over the last 7 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 6%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more